News
3h
Bizcommunity on MSNDanish weight-loss drug Wegovy debuts in South Africa, challenging Eli Lilly
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa, marking its debut in Africa and ...
At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions ...
5h
TipRanks on MSNHere’s Why Wall Street Is Cautious on Hims & Hers Health Stock (HIMS)
Telehealth and wellness platform Hims & Hers Health ($HIMS) recently disappointed investors with its mixed second-quarter ...
At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions ...
Lilly will receive exclusive rights to develop and commercialize drug candidates discovered using Superluminal's AI-driven ...
Researchers uncover ‘dangerous’ threat of global scam operation affecting millions as health regulators warn fraudulent ...
The new price, which also applies to Lilly's type 2 diabetes medicine that has the same name, is effective from September ...
Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop ...
Three stocks that fall into that category today include Lululemon Athletica (NASDAQ: LULU), Novo Nordisk (NYSE: NVO), and ...
Eli Lilly will increase the UK price of its Mounjaro treatment by 170% to match European markets. Despite Novo Nordisk's ...
The US Food and Drug Administration (FDA) has granted de novo authorisation to Artera’s ArteraAI Prostate software.
There’s a calm that the Benin Republic has that can only be experienced, not imagined. I spent a weekend in the small West ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results